DNA Services
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
16
NCT06945614
Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 16, 2025
Completion: Dec 31, 2025
Loading map...